![Peter U. Park](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Peter U. Park
Plus aucun poste en cours
Health Technology
Finance
Profil
Dr. Peter U.
Park is Vice President-Biology at Mersana Therapeutics, Inc.
Dr. Park was previously employed as Chief Executive Officer by Habgen, Inc. and Senior Director-Discovery Research by ImmunoGen, Inc.
He received his undergraduate degree from the Massachusetts Institute of Technology and a doctorate degree from the Massachusetts Institute of Technology.
Anciens postes connus de Peter U. Park
| Sociétés | Poste | Fin |
|---|---|---|
| IMMUNOGEN, INC. | Corporate Officer/Principal | - |
Habgen, Inc. | Directeur Général | - |
| MERSANA THERAPEUTICS | Corporate Officer/Principal | - |
Formation de Peter U. Park
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 4 |
|---|---|
ImmunoGen, Inc.
 ImmunoGen, Inc. BiotechnologyHealth Technology Develops anticancer therapeutics | Health Technology |
Mersana Therapeutics, Inc.
 Mersana Therapeutics, Inc. BiotechnologyHealth Technology Develops and manufactures antibody drug conjugates to improve patient outcomes in multiple oncology indications | Health Technology |
Massachusetts Institute of Technology
 Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
Habgen, Inc. |
